Atlas Trials

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

Clinical trial NCT01380106 · COMPLETED

Trial details

NCT number
NCT01380106
Sponsor
Boston VA Research Institute, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2010-08-01
Primary completion
2017-09-11
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.